SHP099 HCl

SHP099 is a potent, selective, orally bioavailable and potent SHP2 inhibitor. SHP099 exhibits dose-dependent pathway inhibition and antitumor activity in xenograft models. SHP2 is a non-receptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene and is involved in cell growth and differentiation through the MAPK signaling pathway.
Supplier Alfa Cytology
Product # BC0322
Pricing 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire
Feedback